Proximal Protection With The MO.MA Device During Carotid Stenting "ARMOUR"
Completed
Phase N/A ResultsSummary of Purpose
The objective of the ARMOUR study is to evaluate the safety and effectiveness of the Mo.Ma proximal flow blockage cerebral protection device for patients at high surgical risk for carotid endarterectomy who undergo carotid artery stenting
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 25 January 2012.
| 1 Sep 2007 | 29 Aug 2008 | 1 Mar 2009 | 1 Mar 2009 | 1 Jan 2012 | 10 Mar 2010 |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
- Mo.Ma™ Proximal Flow Blockage Cerebral Protection Device (Mo.Ma).
- Carotid Artery Stenting with cerebral protection with the MO.MA device
Conditions
Sponsors
- Invatec, Inc. Lead
- Medtronic Endovascular Lead
Trial Design
- Allocation: Non-Randomized
- Masking: Open Label
- Purpose: Prevention
- Endpoint: Safety/Efficacy Study
- Intervention: Single Group Assignment
Contacts
Not available
View Trial Locations
Recruitment
- Enrollment: 262
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 2 locations, 1 country
Principal Investigator
- L. Nelson Hopkins, MD
Millard Filmore/Gates Hospital
- Gary Ansel, MD
